[Treatment of XXXX in clinical practice and its pharmacoeconomic aspects].

@entity1 @entity6542 @entity2023 @entity34
The present paper aims to analyze therapeutic trends in @entity2023 and their relationships to selected pharmacoeconomic parameters. Health and Disease out- @entity1 records from three out- @entity1 allergologic-immunologic surgeries in the towns of Trenc  n, Nov   Z  mky, and Bratislava were surveyed. The analysis is based on the recorded prescription of drugs prescribed to the @entity1 in the period of his or her "most recent season" in the years 1999-2000. Altogether 279 records (164 females, 115 males) were evaluated. The highest percentage of pollinotics was dispensed in Bratislava (73%) followed by Nov   Z  mky (55%) and Trenc  n (31%). In all three out- @entity1 surgeries, the dominant therapy was a combination of @entity6542 ( @entity6542 ) and @entity34 ( @entity34 , 70-75%). Average costs for one day of treatment of @entity2023 in the out- @entity1 surgeries under study did not significantly differ (22.20-24.50 Sk, the average value of the daily defined dose being 23.20 Sk). Due to confused kept records, the economic analysis did not take into account the financial costs connected with @entity6542 . The present analysis shows a positive state in the field of diagnostics, connected with improved identification of the inducing allergen and application of causal therapy based on @entity6542 (72%). Approximately one third of @entity1 (27%) received only solo medicamentous therapy without application of @entity6542 , and the @entity6542 therapy alone was received by less than 2% of @entity1 (1.4%).
